SCM LIFESCIENCE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,855 KRW | +2.15% |
|
-0.17% | -24.47% |
| 2023 | SCM Lifescience Co., Ltd.(KOSDAQ:A298060) dropped from S&P Global BMI Index | CI |
| 2023 | SCM LifeScience to Raise 30.9 Billion Won via Share Issuance | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
SCM Lifescience Co Ltd is a Korea-based company engaged in the research and development of medicines. The Company is engaged in the business of the development and production of cell therapy products, the agency testing of cell production and quality, adult stem cell consulting, cosmetics manufacturing, and hair growth protein manufacturing.
Calendar
2024-08-08
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -24.47% | 42.73M | |
| +4.49% | 111B | |
| +10.71% | 105B | |
| -12.24% | 22.34B | |
| -3.67% | 21.93B | |
| -5.94% | 18.59B | |
| -36.52% | 18.12B | |
| -9.80% | 16.96B | |
| +3.22% | 13.7B | |
| +37.06% | 12.45B |
- Stock Market
- Equities
- A298060 Stock
- News SCM Lifescience Co., Ltd.
- SCM LifeScience to Raise 30.9 Billion Won via Share Issuance